Literature DB >> 20001084

Procrustean rotation in concert with principal component analysis of molecular dynamics trajectories: Quantifying global and local differences between conformational samples.

Daniel G Oblinsky1, Bryan M B Vanschouwen, Heather L Gordon, Stuart M Rothstein.   

Abstract

Given the principal component analysis (PCA) of a molecular dynamics (MD) conformational trajectory for a model protein, we perform orthogonal Procrustean rotation to "best fit" the PCA squared-loading matrix to that of a target matrix computed for a related but different molecular system. The sum of squared deviations of the elements of the rotated matrix from those of the target, known as the error of fit (EOF), provides a quantitative measure of the dissimilarity between the two conformational samples. To estimate precision of the EOF, we perform bootstrap resampling of the molecular conformations within the trajectories, generating a distribution of EOF values for the system and target. The average EOF per variable is determined and visualized to ascertain where, locally, system and target sample properties differ. We illustrate this approach by analyzing MD trajectories for the wild-type and four selected mutants of the beta1 domain of protein G.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20001084     DOI: 10.1063/1.3268625

Source DB:  PubMed          Journal:  J Chem Phys        ISSN: 0021-9606            Impact factor:   3.488


  2 in total

1.  Variability of the Cyclin-Dependent Kinase 2 Flexibility Without Significant Change in the Initial Conformation of the Protein or Its Environment; a Computational Study.

Authors:  Mohammad Taghizadeh; Bahram Goliaei; Armin Madadkar-Sobhani
Journal:  Iran J Biotechnol       Date:  2016-06       Impact factor: 1.671

2.  The projection analysis of NMR chemical shifts reveals extended EPAC autoinhibition determinants.

Authors:  Rajeevan Selvaratnam; Bryan VanSchouwen; Federico Fogolari; Mohammad T Mazhab-Jafari; Rahul Das; Giuseppe Melacini
Journal:  Biophys J       Date:  2012-02-07       Impact factor: 4.033

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.